IMPACT Study Supports Targeted PSA Screening Based on BRCA1/2 Mutations
Preliminary results from the IMPACT study support the use of targeted PSA screening based on BRCA genotype.
BRCA Gene Mutation
USPSTF Backs Genetic Counseling for BRCA Mutations
Women with a family medical history of BRCA mutations should be offered counseling and genetic testing
Women without the BRCA Mutation but with Family History of BRCA2 Are at Higher Risk for Breast Cancer
Women from BRCA2 families but without the BRCA mutation still have higher breast cancer risk.
Recent News Brings Focus on BRCA Testing and Management
Current events have brought to light issues surrounding BRCA gene mutation testing.
How Will the BRCA Patent Ruling Affect Oncology?
The Supreme Court ruling last week that human genes cannot be patented will lower the cost of BRCA gene tests and open doors to research.
USPSTF Limits BRCA Testing to Women With Family History
Women whose family history is not linked to BRCA mutations should not undergo genetic testing, according to a U.S. Preventive Services Task Force recommendation.
Survival Advantage of BRCA Mutations in Ovarian Cancer is Short-Lived
Survival advantage during three years after diagnosis; no difference in prognosis at 10 years
- Loading...
Loading...
Next post in Gynecologic Cancer
Loading... 
Loading...